4nqn
From Proteopedia
(Difference between revisions)
Line 1: | Line 1: | ||
- | + | ==Crystal Structure of the bromodomain of human BRD9 in complex with a triazolo-phthalazine ligand== | |
- | + | <StructureSection load='4nqn' size='340' side='right' caption='[[4nqn]], [[Resolution|resolution]] 1.73Å' scene=''> | |
- | + | == Structural highlights == | |
- | == | + | <table><tr><td colspan='2'>[[4nqn]] is a 1 chain structure with sequence from [http://en.wikipedia.org/wiki/Human Human]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4NQN OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4NQN FirstGlance]. <br> |
- | [[4nqn]] is a 1 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4NQN OCA]. | + | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=Y1Z:2-CHLORO-N-[5-(3-METHYL[1,2,4]TRIAZOLO[3,4-A]PHTHALAZIN-6-YL)-2-(MORPHOLIN-4-YL)PHENYL]BENZENESULFONAMIDE'>Y1Z</scene></td></tr> |
- | [[Category: Arrowsmith, C H | + | <tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[4nqm|4nqm]]</td></tr> |
- | [[Category: Bountra, C | + | <tr id='gene'><td class="sblockLbl"><b>[[Gene|Gene:]]</b></td><td class="sblockDat">BRD9 ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=9606 HUMAN])</td></tr> |
- | [[Category: Delft, F von | + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4nqn FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4nqn OCA], [http://www.rcsb.org/pdb/explore.do?structureId=4nqn RCSB], [http://www.ebi.ac.uk/pdbsum/4nqn PDBsum]</span></td></tr> |
- | [[Category: Edwards, A M | + | </table> |
- | [[Category: Fedorov, O | + | __TOC__ |
- | [[Category: Felletar, I | + | </StructureSection> |
- | [[Category: Filippakopoulos, P | + | [[Category: Human]] |
- | [[Category: Knapp, S | + | [[Category: Arrowsmith, C H]] |
- | [[Category: Martin, S | + | [[Category: Bountra, C]] |
- | [[Category: Picaud, S | + | [[Category: Delft, F von]] |
- | [[Category: | + | [[Category: Edwards, A M]] |
+ | [[Category: Fedorov, O]] | ||
+ | [[Category: Felletar, I]] | ||
+ | [[Category: Filippakopoulos, P]] | ||
+ | [[Category: Knapp, S]] | ||
+ | [[Category: Martin, S]] | ||
+ | [[Category: Picaud, S]] | ||
+ | [[Category: Structural genomic]] | ||
[[Category: Bromodomain]] | [[Category: Bromodomain]] | ||
[[Category: Inhibition]] | [[Category: Inhibition]] | ||
[[Category: Sgc]] | [[Category: Sgc]] | ||
[[Category: Small molecule inhibitor]] | [[Category: Small molecule inhibitor]] | ||
- | [[Category: Structural genomics consortium]] | ||
[[Category: Transcription]] | [[Category: Transcription]] | ||
[[Category: Transcription-inhibitor complex]] | [[Category: Transcription-inhibitor complex]] |
Revision as of 17:32, 21 December 2014
Crystal Structure of the bromodomain of human BRD9 in complex with a triazolo-phthalazine ligand
|